New treatment possibility for some cancer patients

Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.

Immunotherapy: New Hope for Lung Cancer Patients - Penn Medicine Lancaster General Health

Bladder Cancer Clinical Trials

These New Cancer Drugs Improve Outcomes for People with Hard-to-Treat Tumors

Lung Cancer Clinical Trials: Purpose, Phases, and Risks

TGen News & Press Releases : TGen-UArizona medical school study points to possible new treatment options for breast cancer patients

Experts call for patients to access cancer treatment without delay despite Covid pandemic

Experimental Lung Cancer Treatment: Pros, Cons, Options

Scientists find possible genetic key to why some lymphoma patients don't respond to treatment

Cancer in the Midst of COVID-19, A Report

iCAD's ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease

Lynne Pearce, Page 12

With Low-Risk Prostate Cancer, Treatment Delay Can Be Safe

Opinion Cancer Drug Advancements Give New Hope to Metastatic Patients - The New York Times

New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment - Physician Resources